ITEMS IN AFP WITH KEYWORD:
Telithromycin is similar to clarithromycin with regard to dosing, drug interactions, and effectiveness. It has more frequent and severe adverse effects and is more expensive than other macrolides. Telithromycin should only be used in patients with mild to moderate community-acquired pneumonia caused...
Aug 15, 2007 Issue
Predicting Pneumonia in Adults with Respiratory Illness [Point-of-Care Guides]
Identifying patients with pneumonia (defined as acute respiratory illness with an infiltrate seen on a chest radiograph) is important.
Jun 15, 2006 Issue
Outpatient vs. Inpatient Treatment of Community-Acquired Pneumonia [Point-of-Care Guides]
CAP often is managed in an outpatient setting, an approach endorsed by evidence-based guidelines from the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA).
Patients with community-acquired pneumonia often present with cough, fever, chills, fatigue, dyspnea, rigors, and pleuritic chest pain. When a patient presents with suspected community-acquired pneumonia, the physician should first assess the need for hospitalization using a mortality prediction too...
Oct 15, 2005 Issue
ACCP Releases Consensus Statement on Outpatient Treatment for CAP [Practice Guidelines]
The American College of Chest Physicians (ACCP) recently issued a clinical position statement on outpatient management of community-acquired pneumonia (CAP).
Compared with community-dwelling persons, residents in long-term care facilities have more functional disabilities and underlying medical illnesses and are at increased risk of acquiring infectious diseases. Pneumonia is the leading cause of morbidity and mortality in this group. Risk factors includ...
Community-acquired pneumonia is one of the most common serious infections in children, with an annual incidence of 34 to 40 cases per 1,000 children in Europe and North America. When diagnosing community-acquired pneumonia, physicians should rely mainly on the patient's history and physical examinat...
Recommendations on reducing the incidence of pneumonia and other severe, acute lower respiratory tract infections in acute-care hospitals and in other health care settings have been released by the Centers for Disease Control and Prevention (CDC) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
Atypical organisms such as Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila are implicated in up to 40 percent of cases of community-acquired pneumonia. Antibiotic treatment is empiric and includes coverage for both typical and atypical organisms. Doxycycline, a fluoroquinolon...